U.S. flag

An official website of the United States government

NM_145045.5(ODAD3):c.901A>G (p.Ile301Val) AND Primary ciliary dyskinesia 30

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Feb 1, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000234563.3

Allele description [Variation Report for NM_145045.5(ODAD3):c.901A>G (p.Ile301Val)]

NM_145045.5(ODAD3):c.901A>G (p.Ile301Val)

Gene:
ODAD3:outer dynein arm docking complex subunit 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_145045.5(ODAD3):c.901A>G (p.Ile301Val)
HGVS:
  • NC_000019.10:g.11426206T>C
  • NG_041777.1:g.14577A>G
  • NM_001302453.1:c.739A>G
  • NM_001302454.2:c.721A>G
  • NM_145045.5:c.901A>GMANE SELECT
  • NP_001289382.1:p.Ile247Val
  • NP_001289383.1:p.Ile241Val
  • NP_659482.3:p.Ile301Val
  • NC_000019.9:g.11537026T>C
  • NM_145045.4:c.901A>G
Protein change:
I241V
Links:
dbSNP: rs750661034
NCBI 1000 Genomes Browser:
rs750661034
Molecular consequence:
  • NM_001302453.1:c.739A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001302454.2:c.721A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_145045.5:c.901A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Primary ciliary dyskinesia 30
Synonyms:
CILIARY DYSKINESIA, PRIMARY, 30, WITH OR WITHOUT SITUS INVERSUS
Identifiers:
MONDO: MONDO:0014465; MedGen: C4015016; Orphanet: 244; OMIM: 616037

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000291472Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Feb 1, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV000291472.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces isoleucine with valine at codon 301 of the CCDC151 protein (p.Ile301Val). The isoleucine residue is highly conserved and there is a small physicochemical difference between isoleucine and valine. This variant is present in population databases (rs750661034, ExAC 0.002%) but has not been reported in the literature in individuals with a CCDC151-related disease. The valine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. In addition, algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies. Algorithms developed to predict the effect of nucleotide changes on mRNA splicing suggest that this variant may alter mRNA splicing, but this prediction has not been confirmed by published transcriptional studies. In summary, this is a rare missense change that is not predicted to affect protein function or cause disease but is predicted to affect mRNA splicing. However, the evidence is insufficient at this time to prove either of these predictions conclusively. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 7, 2023